Polyethylene glycol–poly(ε-benzyloxycarbonyl-L-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma

Polyethylene glycol–poly(ε-benzyloxycarbonyl-L-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma

Gangmin Wang,1,* XiaoLong Gao,2,* GuoJun Gu,2 ZhiHong Shao,2 MingHua Li,2 PeiJun Wang,2 JianRong Yang,3 XiaoJun Cai,4 YongYong Li4 1Department of Urology, Huashan Hospital, Fudan University, 2Department of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 3Department of H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang GM, Gao XL, Gu GJ, Shao ZH, Li MH, Wang PJ, Yang JR, Cai XJ, Li YY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
PEG-SS-PLL
VEGF
HepG2
Hepatocellular carcinoma
siRNA.
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/1bacad2097b341fbbb3c5928b7b6f280
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/1bacad2097b341fbbb3c5928b7b6f280

Ejemplares similares